Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-25T14:31:02.485Z Has data issue: false hasContentIssue false
  • English
  • Français

Ziprasidone vs haloperidol for IM/oral therapy of acute schizophrenia

Published online by Cambridge University Press:  16 April 2020

S. Brook ,
W. Jorge  and
I. Benattia
S. Brook
Affiliation:
Sterkfontein Hospital, South Africa
W. Jorge
Affiliation:
University of Freiburg, Germany
I. Benattia
Affiliation:
Pfizer Inc., New York, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Posters, Sunday, 5 May 2002
Information
European Psychiatry , Volume 17 , Issue S1 , May 2002 , pp. 100s - 101s
Copyright
Copyright © Elsevier, Paris 2002
Submit a response

Comments

No Comments have been published for this article.